価格表
在庫・価格 : 2025年04月30日 01時23分 現在
商品名 | 商品コード | メーカー | 包装 | 価格 | 在庫 | リスト |
---|---|---|---|---|---|---|
Anti-ATRX, Rabbit-Poly データシート |
NBP1-83077 |
NOVノバス バイオロジカルス Novus biologicals, LLC |
100 μl | ¥132,000 |
無 (未発注) |
追加 |
在庫・価格 : 2025年04月30日 01時23分 現在
使用文献
- No.: 1
-
文献情報:
de Wilde RF et al. Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumors. Mod. Pathol. 2012 Jul;25(7):1033-9
de Wilde RF et al
2012/01/01
-
備考:
-
参照:
- No.: 2
-
文献情報:
Lovejoy CA et al. Loss of ATRX, Genome Instability, and an Altered DNA Damage Response Are Hallmarks of the Alternative Lengthening of Telomeres Pathway. PLoS Genet 2012 Jul;8(7):e1002772
Lovejoy CA et al
2012/01/01
-
備考:
-
参照:
- No.: 3
-
文献情報:
Bolander A et al. The protein expression of TRP-1 and galectin-1 in cutaneous malignant melanomas. Cancer Genomics Proteomics ;5(6):293-300
Bolander A et al
-
備考:
-
参照:
- No.: 4
-
文献情報:
Schwartzentruber J et al. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 2012 Feb;482(7384):226-31
Schwartzentruber J et al
2012/01/01
-
備考:
-
参照:
- No.: 5
-
文献情報:
Heaphy CM et al. Altered telomeres in tumors with ATRX and DAXX mutations. Science 2011 Jul;333(6041):425
Heaphy CM et al
2011/01/01
-
備考:
-
参照:
- No.: 6
-
文献情報:
Abedalthagafi M et al. The alternative lengthening of telomere phenotype is significantly associated with loss of ATRX expression in high-grade pediatric and adult astrocytomas: a multi-institutional study of 214 astrocytomas. Mod. Pathol. 2013 Nov;26(11)
Abedalthagafi M et al
2013/01/01
-
備考:
-
参照:
- No.: 7
-
文献情報:
Hayashi S et al. Molecular-genetic and clinical characteristics of gliomas with astrocytic appearance and total 1p19q loss in a single institutional consecutive cohort. Oncotarget 2015 Jun;6(18):15871-81
Hayashi S et al
2015/01/01
-
備考:
-
参照:
- No.: 8
-
文献情報:
Yoshida M et al. TERT promoter mutations are frequent and show association with MED12 mutations in phyllodes tumors of the breast. Br. J. Cancer 2015 Oct;113(8):1244-8
Yoshida M et al
2015/01/01
-
備考:
-
参照:
- No.: 9
-
文献情報:
Cryan JB et al. Clinical multiplexed exome sequencing distinguishes adult oligodendroglial neoplasms from astrocytic and mixed lineage gliomas. Oncotarget 2014 Sep;5(18):8083-92
Cryan JB et al
2014/01/01
-
備考:
-
参照:
- No.: 10
-
文献情報:
Cairncross JG et al. Benefit from procarbazine, lomustine, and vincristine in oligodendroglial tumors is associated with mutation of IDH. J. Clin. Oncol. 2014 Mar;32(8):783-90
Cairncross JG et al
2014/01/01
-
備考:
-
参照:
- No.: 11
-
文献情報:
Barszczyk M et al. Telomerase inhibition abolishes the tumorigenicity of pediatric ependymoma tumor-initiating cells. Acta Neuropathol. 2014 Dec;128(6):863-77
Barszczyk M et al
2014/01/01
-
備考:
-
参照:
- No.: 12
-
文献情報:
Nguyen DN et al. Molecular and morphologic correlates of the alternative lengthening of telomeres phenotype in high-grade astrocytomas. Brain Pathol. 2013 May;23(3):237-43
Nguyen DN et al
2013/01/01
-
備考:
-
参照:
- No.: 13
-
文献情報:
Fishbein L et al. Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas. Nat Commun 2015;6:6140
Fishbein L et al
2015/01/01
-
備考:
-
参照:
- No.: 14
-
文献情報:
Jiao Y et al. Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas. Oncotarget 2012 Jul;3(7):709-22
Jiao Y et al
2012/01/01
-
備考:
-
参照:
- No.: 15
-
文献情報:
Haberler C et al. Clinical Neuropathology practice news 2-2014: ATRX, a new candidate biomarker in gliomas. Clin. Neuropathol. ;33(2):108-11
Haberler C et al
-
備考:
-
参照:
- No.: 16
-
文献情報:
Napier CE et al. ATRX represses alternative lengthening of telomeres. Oncotarget 2015 Jun;6(18):16543-58
Napier CE et al
2015/01/01
-
備考:
-
参照: